Clinical Trial Update: A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. [Phase 3]

View source ↗

Summary

Phase 3 study evaluating aztreonam-avibactam ± metronidazole versus meropenem ± colistin for serious Gram-negative infections, including complicated intra-abdom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection
• Hospital-acquired Pneumonia
• Ventilator-associated Pneumonia

Drugs mentioned

• Aztreonam-avibactam (Aztreonam + Avibactam)
• Colistin (colistin)
• METRONIDAZOLE (Metronidazole)
• Meropenem (Meropenem)

Snippet

Sponsor: Pfizer | Conditions: Complicated Intra-abdominal Infection, Hosptial Acquired Pneumonia | Phase 3 | Status: COMPLETED | Results posted: 2024-05-07